Compugen Stock

Compugen EV/EBITDA

Delisted·Jun 15, 2026

The EV/EBITDA (Enterprise Value to EBITDA) of Compugen (CGEN) as of Jul 20, 2026 is 1.72. In the previous year, EV/EBITDA (Enterprise Value to EBITDA) was -6.46 — a change of -126.60% (higher).

EV/EBITDA

1.72

YoY

-126.60%

Last updated:

EV/EBITDA (Enterprise Value to EBITDA) of Compugen is 2026 1.72 . EV/EBITDA (Enterprise Value to EBITDA) of Compugen was 2025 -6.46 . It decreases by -126.60% higher compared to the previous year.
Access this data via the Eulerpool API

Compugen Stock analysis

What does Compugen do? Compugen Ltd is an Israeli biotechnology company focused on the development of therapeutics and diagnostic products. It was founded in 1993 and is headquartered in Tel Aviv. Compugen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Compugen stock

EV/EBITDA (Enterprise Value to EBITDA) of Compugen is 1.72 in 2026.

Access this data via the Eulerpool API

Valuation — Compugen

All Key Metrics — Compugen